NASHVILLE, Tenn. / Oct 31, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences:
November 12, 2025 at 9:30am ET at the 2025 UBS Global Healthcare Conference
November 17, 2025 at 12:00pm ET at the 2025 Wolfe Research Healthcare Conference
A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company’s website, www.hcahealthcare.com.
Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company’s website for the latest information.
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 191 hospitals and approximately 2,500 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom.
All references to “Company” and “HCA” as used throughout this release refer to HCA Healthcare, Inc. and its affiliates.
| Last Trade: | US$459.68 |
| Daily Change: | -7.12 -1.53 |
| Daily Volume: | 1,438,865 |
| Market Cap: | US$107.560B |
October 27, 2025 October 24, 2025 August 27, 2025 July 25, 2025 | |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
